Biométhodes

Biométhodes was a French biotechnology company based in Évry that developed protein engineering and high-throughput mutagenesis technologies, including its Massive Mutagenesis platform. The company appears to have worked on enzyme optimization and therapeutic protein engineering, with historical references to factor VIII optimization as well as industrial biotechnology applications. Over time, the business became associated with and ultimately renamed into Arbiom, shifting strategic focus toward biomass conversion and sustainable protein and biorefinery applications rather than human therapeutics. Available evidence indicates Biométhodes as a standalone company name is no longer active, although the underlying legal entity continued under the Arbiom name.